- Home
- CAVA vs BIO Comparison
CAVA vs BIO Comparison
Compare CAVA & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAVA
- BIO
- Stock Information
- Founded
- CAVA 2006
- BIO 1952
- Country
- CAVA United States
- BIO United States
- Employees
- CAVA N/A
- BIO N/A
- Industry
- CAVA Restaurants
- BIO Biotechnology: Laboratory Analytical Instruments
- Sector
- CAVA Consumer Discretionary
- BIO Industrials
- Exchange
- CAVA Nasdaq
- BIO Nasdaq
- Market Cap
- CAVA 16.2B
- BIO 9.1B
- IPO Year
- CAVA 2023
- BIO N/A
- Fundamental
- Price
- CAVA $112.43
- BIO $342.01
- Analyst Decision
- CAVA Buy
- BIO Strong Buy
- Analyst Count
- CAVA 13
- BIO 4
- Target Price
- CAVA $142.85
- BIO $414.00
- AVG Volume (30 Days)
- CAVA 2.2M
- BIO 158.1K
- Earning Date
- CAVA 02-25-2025
- BIO 02-13-2025
- Dividend Yield
- CAVA N/A
- BIO N/A
- EPS Growth
- CAVA N/A
- BIO N/A
- EPS
- CAVA 0.46
- BIO N/A
- Revenue
- CAVA $913,488,000.00
- BIO $2,580,209,000.00
- Revenue This Year
- CAVA $34.56
- BIO N/A
- Revenue Next Year
- CAVA $23.50
- BIO $2.92
- P/E Ratio
- CAVA $243.55
- BIO N/A
- Revenue Growth
- CAVA 34.05
- BIO N/A
- 52 Week Low
- CAVA $42.65
- BIO $262.12
- 52 Week High
- CAVA $172.43
- BIO $387.99
- Technical
- Relative Strength Index (RSI)
- CAVA 37.56
- BIO 53.78
- Support Level
- CAVA $109.23
- BIO $335.42
- Resistance Level
- CAVA $120.77
- BIO $351.96
- Average True Range (ATR)
- CAVA 3.67
- BIO 9.09
- MACD
- CAVA 0.31
- BIO 2.06
- Stochastic Oscillator
- CAVA 27.72
- BIO 59.23
About CAVA CAVA Group Inc.
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates the majority of its revenue from the CAVA segment.
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.